Guaiazulene
Based on 1 Customer Validation
Guaiazulene is a bicyclic sesquiterpene. Guaiazulene exhibits various biological activities such as anti-inflammatory, antioxidant, hepatoprotective, antibacterial, and anti-tumor properties. Guaiazulene is also commonly used as a colorant in cosmetics. Guaiazulene shows in vitro cytotoxicity to rat neuronal cells and N2a neuroblastoma cells at high concentrations.
For research use only. We do not sell to patients.
- Purity: 99.08%
- CAS No.: 489-84-9
- Formula: C15H18
- Molecular Weight:198.30
-
Storage:Pure form -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
All Caspase Isoforms
More
Biological Activity
Guaiazulene (≥150 μg/mL; 24 h) can reduce the cell viability, inhibit the total antioxidant capacity, but has no obvious DNA damage in N2a and rat neurons[1].
Guaiazulene (5-20 μM; 0-45 min) significantly inhibits lipid peroxidation in rat liver microsomes with an IC50 of 9.8 μM[2].
Guaiazulene (0-250 μM; 48 h) can inhibit the proliferation, reduce clone formation, and induce ROS accumulation and cell apoptosis of non-small cell lung cancer cell lines[3].
Guaiazulene (0-150 μM; 24-48 h) triggers a complete autophagic flux in non-small cell lung cancer cell lines A549 and H1975 by inhibiting the Akt/mTOR signaling pathway[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Primary rat neurons and N2a NB cells
-
Concentration:10, 25, 50, 75, 100, 150, 200, and 400 μg/mL
-
Incubation Time:24 h
-
Result:Did not affect cell viability at 10, 25, 50, 75, and 100 μg/mL
Inhibited the cell viability at 150, 200, and 400 μg/mL.
-
Cell Line:Non-small cell lung cancer cell lines
-
Concentration:0, 50, 100, 150, 200, and 250 μM
-
Incubation Time:48 h
-
Result:Inhibited the cell growth, with IC50 values of 135.0, 144.7, 148.9, 109.5, 152.8, and 207.0 μM for A549, PC9, HCC827, H1975, H1299 and 16HBE, respectively.
Guaiazulene (25 mg/kg; intraperitoneal injection; 3 weeks) exhibits anti-tumor activity in a nude mouse model of A549 xenograft[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Female Fischer-344 rats (180-200 g) treated Acetaminophen (Paracetamol; HY-66005) to induc liver injury[2]
-
Dosage:250 mg/kg
-
Administration:Intraperitoneal injection; single dose
-
Result:Restored the paracetamol-decreased hepatic glutathione level, and normalized other parameters including hepatic weight, cytosolic protein content, glutathione transferase activity, and glutathione reductase activity, which were affected by paracetamol.
Did not cause any macroscopic toxic symptoms, and its administration alone has no effect on all tested indices.
-
Animal Model:Female nude mice (BALB/c, 17-19 g) aged 5 weeks old treated A549 cells[3]
-
Dosage:25 mg/kg
-
Administration:Intraperitoneal injection; 3 weeks
-
Result:Caused smaller size and lighter weight of tumors.
Reduced Ki67 staining intensity, while cleaved-caspase 3 intensity was increased; LC3 staining was stronger and p-Akt levels were decreased in tumor tissues.
Caused no significant changes in mouse weight or pathologic features of major organs (heart, lung, liver, spleen, kidney)
Chemical Information
-
CAS No. 489-84-9
-
Appearance Solid-Liquid Mixture
-
Molecular Weight 198.30
-
Formula C15H18
-
SMILES
CC(C1=CC2=C(C)C=CC2=C(C)C=C1)C
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Pure form -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Solvent & Solubility
DMSO : 50 mg/mL (252.14 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 6.25 mg/mL (31.52 mM); Clear solution
This protocol yields a clear solution of ≥ 6.25 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (62.5 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 6.25 mg/mL (31.52 mM); Clear solution
This protocol yields a clear solution of ≥ 6.25 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (62.5 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation
-
Data Sheet (285 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
[1]. Togar B, et al. Guaiazulene biochemical activity and cytotoxic and genotoxic effects on rat neuron and N2a neuroblastom cells. J Intercult Ethnopharmacol. 2015 Jan-Mar;4(1):29-33. [Content Brief]
[2]. Kourounakis AP, et al. Antioxidant activity of guaiazulene and protection against paracetamol hepatotoxicity in rats. J Pharm Pharmacol. 1997 Sep;49(9):938-42. [Content Brief]
[3]. Ye Q, et al. Guaiazulene Triggers ROS-Induced Apoptosis and Protective Autophagy in Non-small Cell Lung Cancer. Front Pharmacol. 2021 Apr 15;12:621181. [Content Brief]
[4]. Akram W, et al. Guaiazulene and related compounds: A review of current perspective on biomedical applications. Life Sci. 2023 Mar 1;316:121389. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 5.0429 mL | 25.2143 mL | 50.4286 mL | 126.0716 mL |
| 5 mM | 1.0086 mL | 5.0429 mL | 10.0857 mL | 25.2143 mL | |
| 10 mM | 0.5043 mL | 2.5214 mL | 5.0429 mL | 12.6072 mL | |
| 15 mM | 0.3362 mL | 1.6810 mL | 3.3619 mL | 8.4048 mL | |
| 20 mM | 0.2521 mL | 1.2607 mL | 2.5214 mL | 6.3036 mL | |
| 25 mM | 0.2017 mL | 1.0086 mL | 2.0171 mL | 5.0429 mL | |
| 30 mM | 0.1681 mL | 0.8405 mL | 1.6810 mL | 4.2024 mL | |
| 40 mM | 0.1261 mL | 0.6304 mL | 1.2607 mL | 3.1518 mL | |
| 50 mM | 0.1009 mL | 0.5043 mL | 1.0086 mL | 2.5214 mL | |
| 60 mM | 0.0840 mL | 0.4202 mL | 0.8405 mL | 2.1012 mL | |
| 80 mM | 0.0630 mL | 0.3152 mL | 0.6304 mL | 1.5759 mL | |
| 100 mM | 0.0504 mL | 0.2521 mL | 0.5043 mL | 1.2607 mL |